Pulse perturbation technique for determination of piroxicam in pharmaceuticals using an oscillatory reaction system

Pulse perturbation technique for determination of piroxicam in pharmaceuticals using an oscillatory reaction system

Bibliographic Details
Main Authors:	Pejić Nataša, Sarap Nataša, Maksimović Jelena, Anić Slobodan, Kolar-Anić Ljiljana
Format:	Article
Language:	English
Published:	De Gruyter 2013-02-01
Series:	Open Chemistry
Subjects:	piroxicam perturbation technique bray-liebhafsky oscillatory reaction pharmaceutical preparations
Online Access:	https://doi.org/10.2478/s11532-012-0146-7

Similar Items

Activation energies as the validity criterion of a model for complex reactions that can be in oscillatory states
by: Anić S., et al.
Published: (2007-01-01)

Determination of experimental conditions for examination of analytes in Bray-Liebhafsky oscillatory reaction in open reactor conditions
by: Stevanović Kristina Z., et al.
Published: (2017-01-01)

Intermittent Chaos in the CSTR Bray–Liebhafsky Oscillator-Specific Flow Rate Dependence
by: Itana Nuša Bubanja, et al.
Published: (2020-10-01)

Belousov-Zhabotínsky oscillatory reaction. Kinetics of malonic acid decomposition
by: Blagojević Slavica, et al.
Published: (2000-01-01)

Belousov-Zhabotinsky oscillatory reaction. Kinetics of malonic acid decomposition
by: LJILJANA KOLAR-ANIC, et al.
Published: (2000-10-01)

Potentiometric determination of piroxicam and oxfendazole in pharmaceuticals
by: Nagaraju Rajendraprasad, et al.
Published: (2016-01-01)

Analysis of Piroxicam in Pharmaceutical Formulation and Human Urine by Dispersive Liquid–Liquid Microextraction Combined with Spectrophotometry
by: Nakisa Seyyedeh Tutunchi, et al.
Published: (2013-02-01)

Perturbation solutions of fifth order oscillatory nonlinear systems
by: M. Ali Akbar, et al.
Published: (2011-04-01)

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
by: Prabhakar Panzade, et al.
Published: (2017-09-01)

The effect of piroxicam on the formation of postoperative, intraabdominal adhesion in rats
by: Maghsoudi Hemmat, et al.
Published: (2008-01-01)

Study on optimization of ternary complex of piroxicam-β-cyclodextrin-lysine inclusion in supercritical CO2
by: Phan Minh Vuong, et al.
Published: (2021-09-01)

COMPARATIVE EVALUATION OF KETOPROFEN CREAM WITH DICLOFENAC AND PIROXICAM CREAM IN PATIENTS WITH RHEUMATOID ARTHRITIS DISORDERS:
by: Muhammad Razi Ullah Khan, et al.
Published: (2015-01-01)

EVALUATION OF CHONDROPROTECTIVE EFFECTS OF INTRA ARTICULAR PIROXICAM IN POST-TRAUMATIC OSTEOARTHRITIS MODEL OF RAT
by: Noaman Ishaq, et al.
Published: (2021-04-01)

Comparison Efficacy of Topical Piroxicam Gel and Lidocaine with Intravenous Pethidine in Reducing Pain during ESWL
by: F Mohammad Alibeigi, et al.
Published: (2011-06-01)

Effect of piroxicam, metamizol, and S-adenosylmethionine in a murine model of experimental trichomoniasis
by: Nogal-Ruiz J.J., et al.
Published: (2005-03-01)

Self-nanoemulsifying drug delivery system (SNEDDS) of piroxicam: evaluation on anti-inflammantory activity in wistar rats
by: Yudha Rizky Nuari, et al.
Published: (2021-07-01)

Synthesis and biological evaluation of Piroxicam derivative as a lead chelator
by: Hosseini Sayed Masoud, et al.
Published: (2019-06-01)

Comparison the effects of ginger (Zingiber officinale) jelly and piroxicam jelly on pain of knee osteoarthritis
by: Morteza Dehghan, et al.
Published: (2018-04-01)

Simultaneous Determination of Piroxicam and Codeine Phosphate Hemihydrate in a Pharmaceutical Dosage Form Using Validated HPLC Method
by: Ammar Alsaqqa, et al.
Published: (2023-06-01)

Investigating the Effect of Basic Amino Acids and Glucosamine on the Solubility of Ibuprofen and Piroxicam
by: Hadi Valizadeh, et al.
Published: (2023-07-01)

Design, Synthesis, Antinociceptive and Anti-Inflammatory Activities of Novel Piroxicam Analogues
by: Eliezer J. Barreiro, et al.
Published: (2012-11-01)

Piroxicam voltammetric determination by ultra low cost pencil graphite electrode
by: Isaac Yves Lopes de Macêdo, et al.
Published: (2020-03-01)

Thiosemicarbazide derivative-functionalized carbon nanotube for simultaneous determination of isoprenaline and piroxicam
by: Mohammad Mazloum‐Ardakani, et al.
Published: (2017-04-01)

Formulation and evaluation of buccal films of piroxicam co-crystals
by: Anand Ammanage, et al.
Published: (2020-05-01)

SCREENING OF PIROXICAM SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) USING FRACTIONAL FACTORIAL DESIGN
by: Septiawan Adi Nugroho, et al.
Published: (2023-06-01)

Optimization of piroxicam tablet formula using flowlac, avicel and compritol by Simplex Lattice Design Method
by: Tuti Sri Suhesti, et al.
Published: (2009-09-01)

Acute generalized exanthematous pustulosis induced by piroxicam
by: Ingrid Bissinger, et al.
Published: (2016-10-01)

Development and characterization of solid dispersion of piroxicam for improvement of dissolution rate using hydrophilic carriers
by: Mohammad Barzegar-jalali, et al.
Published: (2014-09-01)

Effect of Piroxicam on ART Outcome: A Pilot Study
by: Farnaz Sohrabvand, et al.
Published: (2014-10-01)

Thermodynamic solubility of piroxicam in propylene glycol + water mixtures at 298.2-323.2 K: Data report and modeling
by: Soltanpour Shahla, et al.
Published: (2015-01-01)

Histological changes induced by Piroxicam on the hepatic and renal tissues of mice with and without administration of Peppermint oil
by: Al-Hamdany Muna, et al.
Published: (2022-12-01)

The Effect of Piroxicam Administration before Surgical Removal of Mandibular Mesioangular Third Molar Compared with Acetaminophen.
by: Refoua Y, et al.
Published: (2000-05-01)

Gastroprotective effect of Canna edulis Ker. ethanolic extract in piroxicam-induced rats
by: Dara Pranidya Tilarso, et al.
Published: (2021-03-01)

Role of hydroxypropylmethylcellulose (HPMC 4000) in the protection of the polymorphs of Piroxicam extended release tablets
by: A. Merah, et al.
Published: (2017-02-01)

Photostability of piroxicam in the inclusion complex with 2-hydroxypropyl-β-cyclodextrin
by: Nikolić Vesna D., et al.
Published: (2014-01-01)

Effective method for the detection of piroxicam in human plasma using HPLC
by: Adriana Maria CALVO, et al.
Published: (2016-01-01)

PHARMACOPOEIAL HPLC METHODOLOGY IMPROVEMENT: A CASE STUDY OF PIROXICAM
by: Mikaelly P. Caet, et al.
Published: (2020-12-01)

Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation
by: El-Habashy SE, et al.
Published: (2016-05-01)

Coacervate Thermoresponsive Polysaccharide Nanoparticles as Delivery System for Piroxicam
by: Dorota Lachowicz, et al.
Published: (2020-12-01)

Selective in vitro cytotoxic effects of piroxicam and mefenamic acid on several cancer cells lines.
by: Somchit, M.N, et al.
Published: (2009)